Context Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 5,823 $0.84 $4,903
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 5,606 $0.87 $4,900
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 5,040 $0.97 $4,899
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 7,027 $0.7 $4,898
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 6,839 $0.72 $4,904
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 6,783 $0.74 $4,992
Purchase
MINAI-AZARY JENNIFER LYNN officer: Chief Financial Officer
Common Stock 25,000 $0.74 $18,500
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 20,000 $0.74 $14,800
Purchase
LEVIT ALEX C. officer: Chief Legal Officer, C..
Common Stock 6,000 $0.85 $5,094
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 13,000 $1.85 $24,063
Purchase
MINAI-AZARY JENNIFER LYNN officer: Chief Financial Officer
Common Stock 15,000 $1.8 $27,000
Purchase
SAHMOUD TAREK officer: Chief Medical Officer
Common Stock 10,000 $1.95 $19,500
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 13,000 $3.22 $41,847
Purchase
LEHR MARTIN A. director, officer: Chief Execut..
Common Stock 10,000 $5 $50,000
Purchase
LEVIT ALEX C. officer: Chief Legal Officer, C..
Common Stock 3,000 $5 $15,000

Showing 1 to 15 of 15 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.